Deutsche Bank’s Bionano Genomics BNGO Stock Holding History

Deutsche Bank’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21	Closed	-$7.53K	–	3717
2023 Q2	$7.53K	Sell	21 -377	-95%	-$170K	﹤0.01%	3674
2023 Q1	$265K	Buy	398 +29	+8%	+$25.8K	﹤0.01%	2865
2022 Q4	$324K	Buy	369 +25	+7%	+$31.5K	﹤0.01%	2696
2022 Q3	$377K	Buy	344 +91	+36%	+$120K	﹤0.01%	2553
2022 Q2	$209K	Sell	253 -52	-17%	-$53.5K	﹤0.01%	3135
2022 Q1	$473K	Sell	305 -31	-9%	-$41.8K	﹤0.01%	2784
2021 Q4	$603K	Buy	336 +24	+8%	+$64.2K	﹤0.01%	2722
2021 Q3	$1.03M	Sell	312 -9	-3%	-$31.5K	﹤0.01%	2588
2021 Q2	$1.41M	Buy	+321	New	+$1.27M	﹤0.01%	2547
2019 Q4	–	Sell	-12	Closed	-$5K	–	4989
2019 Q3	$5K	Buy	+12	New	+$13.1K	﹤0.01%	4645
2019 Q1	–	Sell	-7	Closed	-$21K	–	5183
2018 Q4	$21K	Buy	+7	New	+$27.9K	﹤0.01%	4722

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank's BNGO Position: Q3 2023 in Review

Deutsche Bank sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 21 shares — an estimated $7.53K sold.

Deutsche Bank first reported a position in BNGO in Q4 2018 and held it in 11 quarters. The position peaked at $1.41M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Deutsche Bank reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
Deutsche Bank sold 21 Bionano Genomics shares in Q3 2023, an estimated $7.53K.
Deutsche Bank first reported a position in Bionano Genomics in Q4 2018 and held it in 11 quarters.
Deutsche Bank's Bionano Genomics position peaked at $1.41M in Q2 2021.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.